> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Advisory Committee on Epinephrine Nasal Spray
- URL: https://www.fdaweb.com/advisory-committee-on-epinephrine-nasal-spray/
- Published: 2023-03-30T12:00:00.000Z
- Updated: 2026-09-14T18:22:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154108

*Federal Register* notice: FDA has announced a 5/11 Pulmonary-Allergy Drugs Advisory Committee meeting to discuss an ARS Pharmaceuticals NDA for epinephrine nasal spray, indicated for emergency treatment of allergic reactions (Type I) including anaphylaxis in adults and children. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-03-29/pdf/2023-06481.pdf?ref=fdaweb.com).